MB
Madhu Basetti
Also known as: Madhu B, Basetti Madhu, Madhu Basetti, B Madhu
University of Cambridge, Cancer Research UK Cambridge Research Institute, Osmania University, St. George's, University of London
0000-0001-5844-856X
About
Basetti Madhu.MSc 1983, PhD (Physics) 1989, Osmania University,
Hyderabad, India. Worked in Germany and Sweden with MRS and
MRI in biomedical research before joining John Griffiths’ group in
London, UK, in 2000 and (from 2006) Cambridge. Research interests:
Development and application of MRS and MRI methods and NMR-based metabolomics
for understanding the metabolism and biology of cancer. He has
published more than 60 peer-reviewed articles to date.
Employment
-
University of Cambridge Research Scientist2013 - Present
-
Cancer Research UK Cambridge Research Institute Research Scientist2006 - Present
-
St. George's, University of London Researcher2000 - 2006
-
Sahlgrenska universitetssjukhuset Guest scientist1992 - 2000
-
Julius-Maximilians-Universität Würzburg Biozentrum Post-Doc1990 - 1991
Education
-
Osmania University Ph.D.1984 - 1989
-
Osmania University M.Sc.1981 - 1984
-
Osmania University B.Sc1978 - 1981
Projects & Funding
Projects & funding information is unavailable.
Publications (79)
- Imaging and Spectroscopic-Based Methods to Understand Cancer Metabolism and Biology Save
- Survival Pathways of HIF-Deficient Tumour Cells: TCA Inhibition, Peroxisomal Fatty Acid Oxidation Activation and an AMPK-PGC-1α Hypoxia Sensor Save
- Succinate dehydrogenase and MYC-associated factor X mutations in pituitary neuroendocrine tumours Save
- ApcMin/+ tumours and normal mouse small intestines show linear metabolite concentration and DNA cytosine hydroxymethylation gradients from pylorus to colon Save
- A review of the tumour spectrum of germline succinate dehydrogenase gene mutations: Beyond phaeochromocytoma and paraganglioma. Save
- SDHC epi-mutation testing in gastrointestinal stromal tumours and related tumours in clinical practice. Save
- The Factor Inhibiting HIF Asparaginyl Hydroxylase Regulates Oxidative Metabolism and Accelerates Metabolic Adaptation to Hypoxia. Save
- Translating In Vivo Metabolomic Analysis of Succinate Dehydrogenase–Deficient Tumors Into Clinical Utility Save
- SDHA related tumourigenesis: Do we need to test for SDHA gene mutations in clinical practice? Save
- The action of β-hydroxybutyrate on the growth, metabolism and global histone H3 acetylation of spontaneous mouse mammary tumours: evidence of a β-hydroxybutyrate paradox. Save